| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/03/2003 | US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/03/2003 | US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents |
| 04/03/2003 | US20030064074 Recombinant gelatins in vaccines |
| 04/03/2003 | US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy |
| 04/03/2003 | US20030064052 Useful for maintaining controlled and reliable dosage of the therapeutic agent via pulmonary delivery |
| 04/03/2003 | CA2469230A1 Antibody inhibitors of gdf-8 and uses thereof |
| 04/03/2003 | CA2461806A1 Water-soluble phenylpyridazine derivatives and medicines containing the same |
| 04/03/2003 | CA2461714A1 Treatment of chronic joint inflammation |
| 04/03/2003 | CA2461709A1 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | CA2461666A1 Combination therapies for immune mediated diseases |
| 04/03/2003 | CA2461529A1 Recombinant anti-osteopontin antibody and use thereof |
| 04/03/2003 | CA2461504A1 Polymers with structure-defined functions |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461144A1 Preparation and use of pyrrole derivatives for treating obesity |
| 04/03/2003 | CA2461142A1 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity |
| 04/03/2003 | CA2461095A1 Process for making substituted pyrazoles |
| 04/03/2003 | CA2461080A1 Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2460780A1 Autologous growth factor cocktail composition, method of production and use |
| 04/03/2003 | CA2459943A1 Androstanes as androgen receptor modulators |
| 04/03/2003 | CA2459789A1 3-desoxy-vitamin d3 analog esters |
| 04/03/2003 | CA2458279A1 Modulation of vitamin storage |
| 04/02/2003 | EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes |
| 04/02/2003 | EP1298206A1 Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders |
| 04/02/2003 | EP1297842A1 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 04/02/2003 | EP1297833A1 Indole carboxylic acids as thyroid receptor ligands |
| 04/02/2003 | EP1297139A2 G-protein coupled receptor org10 |
| 04/02/2003 | EP1297137A2 Gp286 nucleic acids and polypeptides |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 04/02/2003 | EP1297007A2 Mammalian protein phosphatases |
| 04/02/2003 | EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 04/02/2003 | EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 04/02/2003 | EP1296974A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation |
| 04/02/2003 | EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296959A1 Methods and compositions utilizing quinazolinones |
| 04/02/2003 | EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 04/02/2003 | EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/02/2003 | EP1296929A2 Modified forms of pharmacologically active agents and uses therefor |
| 04/02/2003 | EP1296923A2 Aspirin-triggered lipid mediators |
| 04/02/2003 | EP1296722A2 Radiotherapy |
| 04/02/2003 | EP1296709A1 Solubilised protein vaccines |
| 04/02/2003 | EP1296699A1 Therapeutic agents - iii |
| 04/02/2003 | EP1296698A1 Therapeutic agents - ii |
| 04/02/2003 | EP1296697A1 Therapeutic agents - i |
| 04/02/2003 | EP1296695A2 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 04/02/2003 | EP1296689A2 Method of administering bisphosphonates |
| 04/02/2003 | EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 04/02/2003 | EP1296657A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 04/02/2003 | EP1296644A2 Systems and methods for treating a mucosal surface |
| 04/02/2003 | EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 04/02/2003 | EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 04/02/2003 | EP1212312B1 Novel derivatives of flavones, xanthones and coumarins |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP1135126A4 Myt1 kinase inhibitors |
| 04/02/2003 | EP1114051B1 INHIBITORS OF p38 |
| 04/02/2003 | EP1030842B1 Metalloproteinase inhibitors |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 04/02/2003 | EP0587800B1 Immunomodulatory azaspiranes |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407972A 4-pyrimidine-N-acyl-L-phenylalanines |
| 04/02/2003 | CN1407968A Adamantane derivatives |
| 04/02/2003 | CN1407897A DHEA composition and method |
| 04/02/2003 | CN1406629A Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof |
| 04/02/2003 | CN1406601A Gastrodia tuber composite preparation for hyperosteogeny |
| 04/02/2003 | CN1406600A Medicine for hyperosteogeny |
| 04/02/2003 | CN1406595A Medicine Jiegudan and preparation thereof |
| 04/02/2003 | CN1406594A Oral Chinese medicine for osteoarthritis |
| 04/02/2003 | CN1406587A Use of activated carbon in oral medicinal preparation for hyperthyroidism |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/02/2003 | CN1104412C Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 04/02/2003 | CN1104257C Oesteoblast growth stimulating composition containing PDGF and vitamin D |
| 04/02/2003 | CN1104254C Medicinal liquid for treating bone fracture |
| 04/02/2003 | CN1104251C Osteomyelitis treating medicine |
| 04/02/2003 | CN1104249C Qihe fracture setting plaster with bone retaining liniment |
| 04/02/2003 | CN1104229C Material intended to remineralise organomineral tissues |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541634 Process for preparing growth hormone secretagogues |
| 04/01/2003 | US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector |
| 04/01/2003 | US6541605 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 04/01/2003 | US6541493 Type A, B, C and D crystals of said compound; excellent in stability, and has advantages in handling, storage, and pharmaceutical preparation. |
| 04/01/2003 | US6541492 Thiazole derivatives as PPAR gamma ligands |
| 04/01/2003 | US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example |
| 04/01/2003 | US6541464 For therapy of osteoporosis |
| 04/01/2003 | US6541462 Sphingomyelin enhancement of tumor therapy |
| 03/28/2003 | CA2404045A1 Use of coagulation factor vii-activating protease for the prophylaxis and therapy of vasoproliferative disorders |
| 03/27/2003 | WO2003025542A2 Immune response associated proteins |
| 03/27/2003 | WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 03/27/2003 | WO2003025149A2 Cell populations which co-express cd49c and cd90 |
| 03/27/2003 | WO2003025121A2 Igf-binding protein-derived peptide or small molecule |